Literature DB >> 16086907

Radiotherapy planning for lung cancer: slow CTs allow the drawing of tighter margins.

Karl Wurstbauer1, Heinz Deutschmann, Peter Kopp, Felix Sedlmayer.   

Abstract

BACKGROUND AND
PURPOSE: Evaluation of the use of planning CTs with slow revolution time (4s/slice; 'slow CTs') in the planning procedure of radiotherapy for lung cancer patients in comparison to commonly used 'fast' planning CTs; impact on margin assessment of planning target volume (PTV) design. PATIENTS AND METHODS: Eighteen lung cancer patients (six upper, lower lobe and central tumors, respectively) have been scanned each by three series of slow CTs and one fast CT (spiral CT). Patients have been freely breathing. The largest transversal tumor diameters in slow and fast CTs have been measured. Tumor edge positions have been determined for six spatial directions in all slices of the three slow CT series.
RESULTS: Slow CTs show larger dimensions of the visible tumor than fast CTs. The median difference of the diameter for all tumors is 2mm (range 0-4mm). Slow CTs deliver constant depictions of lung tumors within a range of 1.6mm in all directions. This margin is considered to be sufficient to compensate for tumor movements by respiration and cardiovascular motions (internal margin). A margin of 7 mm added to the GTV of a single slow CT series to draw the PTV is proposed.
CONCLUSIONS: Slow planning CTs show larger, but highly constant depictions of lung tumors in comparison to conventional fast CT scanning, yielding an integral delineation of almost all positions of the moving tumors. Thus the use of slow planning CTs enables the drawing of tighter margins in external beam treatment planning of lung cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16086907     DOI: 10.1016/j.radonc.2005.02.003

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  16 in total

1.  The potential for undertaking slow CT using a modern CT scanner.

Authors:  C D Chinneck; M McJury; A R Hounsell
Journal:  Br J Radiol       Date:  2010-06-15       Impact factor: 3.039

2.  The importance of surrounding tissues and window settings for contouring of moving targets.

Authors:  Kai Joachim Borm; Markus Oechsner; Johannes Berndt; Stephanie Elisabeth Combs; Michael Molls; Marciana Nona Duma
Journal:  Strahlenther Onkol       Date:  2015-06-19       Impact factor: 3.621

3.  Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer.

Authors:  Meritxell Mollà; Jordi Saez; Monica Ramos; Alexandra Giraldo; Alejandro Seoane; Jordi Andreu; Marc Simó; Jordi Giralt
Journal:  Br J Radiol       Date:  2016-03-17       Impact factor: 3.039

4.  Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiotherapy with doses ≥ 80 Gy in standard fractionation.

Authors:  Karl Wurstbauer; Hannes Weise; Heinz Deutschmann; Peter Kopp; Florian Merz; Michael Studnicka; Olaf Nairz; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

5.  Interobserver variability of patient positioning using four different CT datasets for image registration in lung stereotactic body radiotherapy.

Authors:  Markus Oechsner; Barbara Chizzali; Michal Devecka; Stefan Münch; Stephanie Elisabeth Combs; Jan Jakob Wilkens; Marciana Nona Duma
Journal:  Strahlenther Onkol       Date:  2017-07-19       Impact factor: 3.621

6.  Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

Authors:  Karl Wurstbauer; Florian Merz; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

7.  Phantom investigation of 3D motion-dependent volume aliasing during CT simulation for radiation therapy planning.

Authors:  James A Tanyi; Martin Fuss; Vladimir Varchena; Jack L Lancaster; Bill J Salter
Journal:  Radiat Oncol       Date:  2007-02-24       Impact factor: 3.481

8.  Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans.

Authors:  Karl Wurstbauer; Heinz Deutschmann; Peter Kopp; Florian Merz; Helmut Schöller; Felix Sedlmayer
Journal:  Radiat Oncol       Date:  2009-08-14       Impact factor: 3.481

9.  DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.

Authors:  Karl Wurstbauer; Heinz Deutschmann; Karin Dagn; Peter Kopp; Franz Zehentmayr; Bernd Lamprecht; Peter Porsch; Birgit Wegleitner; Michael Studnicka; Felix Sedlmayer
Journal:  Radiat Oncol       Date:  2013-03-05       Impact factor: 3.481

10.  Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study.

Authors:  Coen W Hurkmans; Johan P Cuijpers; Frank J Lagerwaard; Joachim Widder; Uulke A van der Heide; Danny Schuring; Suresh Senan
Journal:  Radiat Oncol       Date:  2009-01-12       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.